Figure 6.
Incidence of cardiovascular events and all‐cause mortality with empagliflozin (pooled) versus placebo in the meta‐analysis excluding EMPA‐REG OUTCOME.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.